Better Bones & Joints References

Oct. 10 2005 Natural Products INSIDER
"Bone and Joint" References

1. Englund U et al. “A 1-year combined weight-bearing training program is beneficial for bone mineral density and neuromuscular function in older women.” Osteoporos Int. 16, 9:1117-23, 2005. http://www.springeronline.com/sgw/cda/frontpage/0,11855,5-10054-70-1102329-0,00.html

2. Swenson KK et al. “Interventions to prevent loss of bone mineral density in women receiving chemotherapy for breast cancer.” Clin J Oncol Nurs. 9, 2:177-84, 2005.

3. Shea B et al. "Calcium supplementation on bone loss in postmenopausal women." Cochrane Database Syst Rev. 1:CD004526, 2004. www.medlib.com/spi/cdsr.htm

4. Chee WS et al. "The effect of milk supplementation on bone mineral density in postmenopausal Chinese women in Malaysia." Osteoporos Int. 14, 10:828-34, 2003. www.link.springer.de/link/service/journals/00198

5. Teegarden D et al. “Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss.” J Clin Endocrinol Metab. 90, 9:5127-33, 2005. http://jcem.endojournals.org

6. Dobson A et al. “Improving Public Health, Reducing Health Care Costs: An Evidence-Based Study of Five Dietary Supplements:  Fact Sheet.” The Lewin Group, September 2004. www.lewin.com

7. Newmark HL et al. “Should calcium and vitamin D be added to the current enrichment program for cereal-grain products?” Amer J Clin Nutr. 80, 2:264-70, 2004. www.ajcn.org

8. Grant AM et al. “Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.” Lancet. 365, 9471:1621-8, 2005. www.thelancet.com

9. Malabanan AO, Holick MF. "Vitamin D and bone health in postmenopausal women." J Womens Health (Larchmt). 12, 2:151-6, 2003.

10. Pasco JA et al. "Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption and fractures: the Geelong Osteoporosis Study." J Bone Miner Res. 19, 5:752-8, 2004. www.jbmr-online.org

11. Nuti R et al. "Vitamin D status and bone turnover in women with acute hip fracture." Clin Orthop. 422:208-13, 2004. www.corronline.com

12. Matsumoto T et al. “A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial.” J Clin Endocrinol Metab. 90, 9:5031-6, 2005. http://jcem.endojournals.org

13. Heaney RP. "Phosphorus nutrition and the treatment of osteoporosis." Mayo Clin Proc. 79, 1:91-7, 2004. www.mayo.edu/proceedings

14. Kawauru A et al. “Phosphorus intake and bone mineral density (BMD)” Clin Calcium. 15, 9:1501-6, 2005.

15. Rude RK et al. "Magnesium deficiency: effect on bone and mineral metabolism in the mouse." Calcif Tissue Int. 72, 1:32-41, 2003.

16. Stendig-Lindberg G et al. "Experimentally induced prolonged magnesium deficiency causes osteoporosis in the rat." Eur J Intern Med. 15, 2:97-107, 2004.

17. Rude RK and Gruber HE. “Magnesium deficiency and osteoporosis: animal and human observations.” J Nutr Biochem. 15, 12:710-6, 2004. http://www.sciencedirect.com/science/journal/09552863

18. Going SB et al. “Dietary iron positively influences bone mineral density in postmenopausal women on hormone replacement therapy. J Nutr. 135, 4:863-9, 2005. www.nutrition.org

19. Maggio D et al. "Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study." J Clin Endocrinol Metab. 88, 4:1523-7, 2003. http://jcem.endojournals.org

20. Turan B, Can B, Delilbasi E. "Selenium combined with vitamin E and vitamin C restores structural alterations of bones in heparin-induced osteoporosis." Clin Rheumatol. 22, 6:432-6, 2003. http://link.springer.de/link/service/journals/10067

21. Wolf RL et al. “Lack of a relation between vitamin and mineral antioxidants and bone mineral density: results from the Women's Health Initiative.” Am J Clin Nutr. 82, 3:581-8, 2005. www.ajcn.org

22. Kneissel M et al. “Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents.” Bone. 36, 2:202-14, 2005. http://www.sciencedirect.com/science/journal/87563282

23. Sato Y et al. “Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.” JAMA. 293, 9:1082-8, 2005. http://jama-assn.org

24. Ryan-Harshman M, Aldoori W. "Bone health. New role for vitamin K?" Can Fam Physician. 50:993-7, 2004. www.cfpc.ca/communications/cfp/cfpindex.asp

25. Sun L et al. "Inhibition of osteoporosis induced by protein deficient food intake by active vitamin D(3) and vitamin K(2) in rats." Biosci Biotechnol Biochem. 68, 6:1385-7, 2004. www.jsbba.or.jp/bbindexj.html

26. Devine A et al. “Protein consumption is an important predictor of lower limb bone mass in elderly women.”Am J Clin Nutr. 81, 6:1423-28, 2005. www.ajcn.org

27. Messina M, Messina V. "Soyfoods, soybean isoflavones and bone health: a brief overview." J Ren Nutr. 10, 2:63-8, 2000. www.jrnjournal.org

28. Shu, XO et al. “Prospective cohort study of soy food consumption and risk of bone fracture among postmenopausal women.” Arch Intern Med. 165, 16:1890-5, 2005. http://archinte.ama-assn.org

29. Arjmandi BH and Smith BJ. “Soy isoflavones' osteoprotective role in postmenopausal women: mechanism of action.” J Nutr Biochem. 13, 3:130-137, 2002. http://www.sciencedirect.com/science/journal/09552863

30. Chen YM et al. “Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial.” J Clin Endocrinol Metab. 88, 10:4740-7, 2003. http://jcem.endojournals.org

31. Watkins BA et al. “Omega-3 polyunsaturated fatty acids and skeletal health.” Exp Biol Med. 226, 6:485-97, 2001. www.ebmonline.org

32. Weiss LA et al. “Ratio of n-6 to n-3 fatty acids and bone mineral density in older adults: the Rancho Bernardo Study.”Am J Clin Nutr. 81, 4:934-8, 2005. www.ajcn.org

33. Sun D et al. “Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice.” J Bone Miner Res. 18, 7:1206-16, 2003. www.jbmr-online.org

34. Yao Ch et al. “Fabrication and evaluation of a new composite composed of tricalcium phosphate, gelatin, and Chinese medicine as a bone substitute.” J Biomed Mater Res B Appl Biomater. Epub ahead of print, Jul 15, 2005. http://www3.interscience.wiley.com/cgi-bin/jhome/96516924

35. Abrams SA et al. “A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents.” Am J Clin Nutr. 82, 2:471-6, 2005. www.ajcn.org

36. Das AS, Mukherjee M, Mitra C. "Evidence for a prospective anti-osteoporosis effect of black tea (Camellia Senensis) extract in a bilaterally ovariectomized rat model." Asia Pac J Clin Nutr. 13, 2:210-6, 2004.

37. Mukherjee M et al. "Prevention of bone loss by oil extract of garlic (Allium sativum Linn.) in an ovariectomized rat model of osteoporosis." Phytother Res. 18, 5:389-94, 2004. www.interscience.wiley.com/jpages/0951-418X

38. Kamenicek V, Holan P, Franek P. "[Systemic enzyme therapy in the treatment and prevention of post-traumatic and postoperative swelling.]" Acta Chir Orthop Traumatol Cech. 68, 1:45-9, 2001.

39. Jacques P et al. “Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?” Arthritis Rheum. 39, 4:648-56, 1996.

40. Clark AG et al. “The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants.” Matrix Biol. 21, 2:175-84, 2002.

41. Kurz B et al. “Dietary vitamins and selenium diminish the development of mechanically induced osteoarthritis and increase the expression of antioxidative enzymes in the knee joint of STR/1N mice.” Osteoarth Cartil. 10, 2:119-26, 2002.

42. McAlindon TE et al. “Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham Study.” Ann Intern Med. 125, 5:353-9, 1996. www.annals.org

43. lane NE et al. “Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group.” Arthritis Rheum. 42, 5:854-60, 1999.

44. Glowacki J et al. “Osteoporosis and vitamin-D deficiency among postmenopausal women with osteoarthritis undergoing total hip arthroplasty.” J Bone Joint Surg Am. 85, 12:2371-7, 2003. www.ejbjs.org

45. Reginster JY et al. “Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.” Lancet. 357, 9252:251-6, 2001. www.thelancet.com

46. Halbekath J et al. “Glucosamine sulphate and osteoarthritis.” Lancet. 357, 9268:1617, 2001. www.thelancet.com

47. Bruyere O et al. “Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies.” Menopause. 11, 2:138-43, 2004. www.menopausejournal.com

48. Pavelka K et al. “Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.” Arch Intern Med. 162, 18:2113-23, 2002. http://archinte.ama-assn.org/

49. Thie NM et al. “Evaluation of glucosamine sulfate compared to ibuprofen for the treatment of temporomandibular joint osteoarthritis: a randomized double blind controlled 3 month clinical trial.” J Rheumatol. 28, 6:1347-55, 2001. www.jrheum.com

50. Mazieres B et al. “Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study.” J Rheumatol. 28, 1:173-81, 2001. www.jrheum.com

51. Uebelhart D et al. “Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo.” Osteoarth Cartil. 12, 4:269-76, 2004.

52. Debi R et al. “[GAG for osteoarthritis of the knee--a prospective study.]” Harefuah. 138, 6:451-3, 518, 2000.

53. Rossi A et al. “In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.” Pediatr Pathol Mol Med. 22, 4:311-21, 2003.

54. Berg P and Olsson U. “Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study.” Clin Exp Rheumatol. 22, 3:300-6, 2004.

55. Karatay S et al. “Effects of different hyaluronic acid products on synovial fluid levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in knee osteoarthritis.” Ann Clin Lab Sci. 34, 3:330-5, 2004.

56. Oesser S and Seifert J. “Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen.” Cell Tissue Res. 311, 3:393-9, 2003. ww.springeronline.com

57. Moskowitz RW. “Role of collagen hydrolysate in bone and joint disease.” Semin Arthritis Rheum. 30, 2:87-99, 2000. http://journals.elsevierhealth.com

58. Kalman DS et al. “A randomised double-blind clinical pilot trial evaluating the safety and efficacy of hydrolysed collagen type II in adults with osteoarthritis.” FASEB. LB435:A90, 2004. www.fasebj.org

59. DeParle L et al. “Efficacy and safety of glycosated undenatured type II collagen (UC-II) in arthritic dogs.” J Amer Coll Nutr. 45th Annual Meeting, 2004.

60. Gupta R et al. “Therapeutic efficacy and safety of glycosated undenatured type II collagen derivative (UC-II) in arthritic dogs.” Presented at Society of Toxicology Annual Meeting, 2005.

61. Moreau M et al. “Clinical evaluation of a powder of quality elk velvet antler for the treatment of osteoarthrosis in dogs.” Can Vet J. 45, 2:133-9, 2004.

62. Kimmatkar N et al. “Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee--a randomized double blind placebo controlled trial.” Phytomed. 10, 1:3-7, 2003. www.elsevier-deutschland.de/phytomed

63. Singh BB et al. “The effectiveness of Commiphora mukul for osteoarthritis of the knee: an outcomes study.” Altern Ther Health Med. 9, 3:74-9, 2003.

64. Gagnier JJ et al. “Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review.” BMC Complement Altern Med. 4, 1:13, 2004. www.biomedcentral.com

65. Andersen ML et al. “Evaluation of acute and chronic treatments with Harpagophytum procumbens on Freund's adjuvant-induced arthritis in rats.” J Ethnopharmacol. 91, 2-3:325-30, 2004. http://www.sciencedirect.com/science/journal/03788741

66. Schmid B et al. “Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial.” Phytother Res. 15, 4:344-50, 2001. http://www3.interscience.wiley.com/cgi-bin/jhome/12567

67. Innes JF et al. “Randomised, double-blind, placebo-controlled, parallel group study of P54FP for the treatment of dogs with osteoarthritis.” Vet Rec. 152, 15:457-60, 2003.

68. Liacini A et al. “Triptolide suppresses proinflammatory cytokine-induced matrix metalloproteinase and aggrecanase-1 gene expression in chondrocytes.” Biochem Biophys Res Commun. 327, 1:320-7, 2005. http://www.sciencedirect.com/science/journal/0006291X

69. Walker AF et al. “Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults.” Phytomed. 9, 8:681-6, 2002. www.elsevier-deutschland.de/phytomed

70. Akhtar NM et al. “Oral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized study.” Clin Rheumatol. 23, 5:410-5, 2004. www.springerlink.com

71. Hesslink R et al. “Cetylated fatty acids improve knee function in patients with osteoarthritis.” J Rheumatol. 29, 8:1708-12, 2002. www.jrheum.com

72. Kraemer WJ et al. “Effect of a cetylated fatty acid topical cream on functional mobility and quality of life of patients with osteoarthritis.” J Rheumatol. 31, 4:767-74, 2004. www.jrheum.com

73. Ratamass NA et al. “Effects of treatment with a cetylated fatty acid topical cream on static postural stability and plantar pressure distribution in patients with knee osteoarthritis.” J Strength Cond Res. 19, 1:115-21, 2005. http://nsca.allenpress.com

74a. Colker CM et al. “ffects of a milk-based bioactive micronutrient beverage on pain symptoms and activity of adults with osteoarthritis: a double-blind, placebo-controlled clinical evaluation.’ Nutrition. 18, 5:388-92, 2002. http://www.journals.elsevierhealth.com/periodicals/nut/home

74b. Zenk JL et al. “The effects of milk protein concentrate on the symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo-controlled trial.” Curr Thera Res. 63, 7:43042, 2002. http://www.sciencedirect.com/science/journal/0011393X

75. Hagfors L et al. "Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis." Nutr J. 2, 1:5, 2003. www.nutritionj.com

76. Cerhan JR et al. “Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women.” Am J Epidemiol. 157, 4:345-54, 2003. www.aje.oupjournals.org

77. Kiziltunic A et al. “Carnitine and antioxidants levels in patients with rheumatoid arthritis.” Scand J Rheumatol. 27, 6:441-5, 1998.

78. Lee SJ et al. “Astaxanthin inhibits nitric oxide production and inflammatory gene expression by suppressing I(kappa)B kinase-dependent NF-kappaB activation.” Mol Cells. 16, 1:97-105, 2003. www.molcells.org

79. Spiller GA and Nir Y. “ BioAstin helps relieve pain and improves performance in patients with rheumatoid arthritis.” Healh Research and Studies Center, Los Altos, Calif., 2002.

80. Furse RK et al. “Oral administration of gamma linolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes.” J Clin Immunol. 22, 2:83-91, 2002. www.kluweronline.com/issn/0271-9142/current

81. Brzeski M et al. “Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs.” Br J Rheumatol. 30, 5:370-2, 1991.

82. Laposata m et al. “Alteration of the cellular fatty acid profile and the production of eicosanoids in human monocytes by gamma-linolenic acid.” Arthritis Rheumatism. 33, 10:1526-33, 1990. www3.interscience.wiley.com/cgi-bin/currentissue?ID=76509746

83. Watson J et al. “Cytokine and prostaglandin production by monocytes of volunteers and rheumatoid arthritis patients treated with dietary supplements of blackcurrant seed oil.” Br J Rheumatol. 32, 12:1055-8, 1993.

684. Boyce EG et al. “Treatment of rheumatoid arthritis with blackcurrant seed oil.” Br J Rheumatol. 33, 9:847-52, 1994.

85. Nordstrom DC et al. “Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study: flaxseed vs. safflower seed.” Rheumatol Int. 14, 6:231-4, 1995.

86. James MJ et al. “Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease issues and obstacles for use in rheumatoid arthritis.” Prostagland Leukotr Essent Fatty Acids. 68, 6:399-405, 2003. www.harcourt-international.com/journals/plef

87. Cleland LG et al. “The role of fish oils in the treatment of rheumatoid arthritis.” Drugs. 63, 9:845-53, 2003.

88. Kless T et el. “Anti-inflammatory effects of a low arachidonic acid diet and fish oil in patients with rheumatoid arthritis.” Rheumatol Int. 23, 1:27-36, 2003.

89. Oh R. J. “Practical Applications of Fish Oil (n-3 Fatty Acids) in Primary Care.” Amer Board Fam Pract. 18, 1:28-36, 2005. http://www.jabfp.org

90. Gruenwald J et al. “Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders.” Adv Ther. 21, 3:197-201, 2004.

91. Halpern GM. “Anti-inflammatory effects of a stabilized lipid extract of Perna canaliculus, Lyprinol.” Allerg Immunol. 32, 7:272-8, 2000.

92. Bagchi D et al. “Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases:a mechanistic exploration.” Int J Clin Pharmacol Res. 22:101-10, 2002.

93. Trentham DE et al. “Effects of oral administration of type II collagen on rheumatoid arthritis.” Science. 261, 5129:1727-30, 1993. www.sciencemag.org

94. Ausar SF et al. “Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen.” Rheumatol Int. 20, 4:138-44, 2001.

95. Abdullaeva GK and Shakimova BS. “[An evaluation of the efficacy of treating rheumatoid arthritis with preparations for local use]” Revmatologiia (Mosk). 4:35-9, 1985.

96. Anikina NV et al. “[The effect of dimethyl sulfoxide on the thromboelastographic indices and the microcirculation in patients with rheumatic diseases]” Ter Arkh. 61, 12:106-9, 1989.

97. Kontny E et al. “Impaired generation of taurine chloramine by synovial fluid neutrophils of rheumatoid arthritis patients.” Amino Acids. 23, 4:415-8, 2002.

98. Wilkinson LJ and Waring RH. “Cysteine dioxygenase: modulation of expression in human cell lines by cytokines and control of sulphate production.” Toxicol In Vitro. 16, 4:481-3.

99. Zafarullah M et al. “Molecular mechanisms of N-acetylcysteine actions.” Cell Mol Life Sci. 60, 1:6-20, 2003

100. Muller G et al. “COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage.” Connect Tissue Res. 39, 4:233-44, 1998.

101. Srivastava KC and Mustafa T. “Ginger , Zingiber officinale) and rheumatic disorders.” Med Hypotheses. 29, 1:25-8, 1989. www.harcourt-international.com/journals/mehy

102. Sharma JN. “Comparison of the anti-inflammatory activity of Commiphora mukul , an indigenous drug) with those of phenylbutazone and ibuprofen in experimental arthritis induced by mycobacterial adjuvant.” Arzneimittelforschung. 27, 7:1455-7, 1977.

103.Zhang XJ et al. “Anti-inflammatory actions of cat’s claw: the role of NF-kappaB.” Aliment Pharmacol Ther. 12, 12:1279-89, 1998.

104. Miller JS et al. “Suppression of human cartilage degradation and chondrocyte activation by a unique mineral supplement (SierraSil<\#170>) and a cat’s claw extract, Vincaria<\#168>.” J Amer Nutra Assoc. 7, 2:32-9, 2004. www.americanutra.com

105. Behnke B et al. “Effects of the antirheumatic remedy hox alpha--a new stinging nettle leaf extract--on matrix metalloproteinases in human chondrocytes in vitro.” Histol Histopathol. 17, 2:477-85, 2002.

106. Broer J and Behnke B. “Immunosuppressant effect of IDS 30, a stinging nettle leaf extract, on myeloid dendritic cells in vitro.” J Rheumatol. 29, 4:656-8, 2002. www.jrheum.com

107. Gonzalez PA et al. “Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse.” J Pharmacol Exp Ther. 312, 1:366-72, 2005.

108. Roy S et al. “Human Genome Screen to Identify the Genetic Basis of the Anti-inflammatory Effects of Boswellia in Microvascular Endothelial Cells.” DNA Cell Biol. 24, 4:244-55, 2005.

109. Ammon HP. “[Boswellic acids , components of frankincense) as the active principle in treatment of chronic inflammatory diseases]” Wien Med Wochenschr. 152:373-8, 2002.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines